Favorites chosen by Cleveland Clinic’s Hematology and Medical Oncology staff
Cleveland Clinic study of 3.7 million patients
Pembrolizumab stabilizes cancer in some patients
Axitinib and crizotinib stabilized disease in most
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Inhibitor stops DNA repair of cancer cells
Doctors will analyze whether survival improves
May increase some pancreatic cancer survival rates
Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASCO Annual Meeting
Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASCO Annual Meeting
Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASCO Annual Meeting